Rare eye condition prompts new FDA warning on popular GLP-1 drugs | HappeningNow.news

Health · 3 views

Rare eye condition prompts new FDA warning on popular GLP-1 drugs

The U.S. Food and Drug Administration (FDA) is requiring makers of Ozempic, Wegovy and similar drugs to warn of a rare eye condition that can cause vision loss.

Source Summary Published 45m ago Brief Under 1 min brief
Story intelligence
Coverage Single outlet Single-outlet story
Views 3 Community interest
Brief read Under 1 min brief 59 words

Summary

The U.S. Food and Drug Administration (FDA) is requiring makers of Ozempic, Wegovy and similar drugs to warn of a rare eye condition that can cause vision loss. The condition is called non-arteritic anterior ischemic optic neuropathy (NAION). It happens when blood flow drops to part of the optic nerve, which carries signals from the eye to the brain.

Read original at Medical Xpress

More from Health

Continue reading recent Health coverage

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page